| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/27/2002 | WO2002050073A1 Pyrazolo[3,4-c]pyridines as gsk-3 inhibitors |
| 06/27/2002 | WO2002050066A2 Pyrazole compounds useful as protein kinase inhibitors |
| 06/27/2002 | WO2002050065A2 Pyrazole compounds useful as protein kinase inhibitors |
| 06/27/2002 | WO2002050061A1 Piperazine derivatives for treatment of bacterial infections |
| 06/27/2002 | WO2002050051A1 Chemical compounds |
| 06/27/2002 | WO2002050045A1 Antiviral agents |
| 06/27/2002 | WO2002050041A1 Dihydroindole and tetrahydroquinoline derivatives |
| 06/27/2002 | WO2002050040A1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperazine-containing moiety and their use as antibacterial agents |
| 06/27/2002 | WO2002050039A1 Urea and urethane derivatives as integrin inhibitors |
| 06/27/2002 | WO2002050033A1 Benzo(f) isoindol derivatives and their use as ep4 receptor ligands |
| 06/27/2002 | WO2002050032A1 Naphthalene derivatives which bind to the ep4 receptor |
| 06/27/2002 | WO2002050031A1 Indole derivatives |
| 06/27/2002 | WO2002050030A2 Cycloalkylfused [g]-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases |
| 06/27/2002 | WO2002050029A2 Tetracyclic derivatives as spla2 inhibitors |
| 06/27/2002 | WO2002050028A2 Substituted benzoindoles as spla2 inhibitors |
| 06/27/2002 | WO2002050024A2 Thiazolidinediones |
| 06/27/2002 | WO2002050021A1 Nitric oxide synthase inhibitor phosphate salt |
| 06/27/2002 | WO2002050019A2 Diamines as modulators of chemokine receptor activity |
| 06/27/2002 | WO2002049993A2 High affinity small molecule c5a receptor modulators |
| 06/27/2002 | WO2002049668A1 Use of compatible solutes as adjuvants for vaccines |
| 06/27/2002 | WO2002049666A2 Mycoplasma hyopneumoniae bacterin vaccine |
| 06/27/2002 | WO2002049658A1 A method to enhance the immune system and used for the prevention and treatment of infectious diseases |
| 06/27/2002 | WO2002049650A2 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives |
| 06/27/2002 | WO2002049633A2 Use of amidoamines to treat or prevent acanthamoeba and fungal infections |
| 06/27/2002 | WO2002049631A1 Propofol formulation with enhanced microbial inhibition |
| 06/27/2002 | WO2002049627A2 Antifungal compositions containing an antibiotic and one or more amidoamines |
| 06/27/2002 | WO2002049625A2 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds |
| 06/27/2002 | WO2002049618A1 Amoxycillin pellets |
| 06/27/2002 | WO2002049577A2 Analogues of thiocoraline and be-22179 |
| 06/27/2002 | WO2002049557A1 Method for the prevention, inhibition, or treatment of vaginitis and/or bacterial vaginosis using polystyrene sulfonate |
| 06/27/2002 | WO2002049501A2 Local regional chemotherapy and radiotherapy using in situ hydrogel |
| 06/27/2002 | WO2002030353A3 NF-λB INHIBITORS |
| 06/27/2002 | WO2002022602A3 Triazole compounds useful as protein kinase inhibitors |
| 06/27/2002 | WO2002022168A3 Vaccine against streptococcus pneumoniae |
| 06/27/2002 | WO2002022167A3 Vaccine against streptococcus penumoniae |
| 06/27/2002 | WO2002020822A3 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 06/27/2002 | WO2002020566A3 NOVEL MMP-2 DERIVATIVES FOR USE AS INHIBITORS OF INTEGRIN αVβ¿3? |
| 06/27/2002 | WO2002009648A3 Antimicrobial biaryl compounds |
| 06/27/2002 | WO2002007516A3 Uses for nad synthetase inhibitors |
| 06/27/2002 | WO2002006821A3 Antimicrobial agent |
| 06/27/2002 | WO2002000882A3 Transport peptides dirived from erns protein, cytotoxic rnase of ribosome-inactivating protein or a rsv g-protein and analogues thereof |
| 06/27/2002 | WO2002000616A3 Novel cephalosporin compounds and process for preparing the same |
| 06/27/2002 | WO2001092288A3 Cobalamin compounds useful as antibiotic agents and as imaging agents |
| 06/27/2002 | WO2001089509A3 Method of treating hiv-1 disease |
| 06/27/2002 | WO2001054680A3 Method for using potassium channel activation for delivering a medicant to an abnormal brain region and/or a malignant tumor |
| 06/27/2002 | WO2001038358A9 Hbv/hcv virus-like particle |
| 06/27/2002 | WO2001035994A3 Chitosan induced immunopotentiation |
| 06/27/2002 | WO2001014536A3 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 06/27/2002 | WO2000071561A9 Cd4-independent hiv envelope proteins as vaccines and therapeutics |
| 06/27/2002 | US20020082780 Natural, anti-bacterial, anti-virus, anti-herpes cream |
| 06/27/2002 | US20020082571 Method of using lectins for agglutination and collection of menstrual flow |
| 06/27/2002 | US20020082395 Immunoglobulin for use in diagnosis, treatment and prevention of bacterial infections |
| 06/27/2002 | US20020082386 Monoclonal antibody for use in the detecion and prevention of bacillus anthracis infections |
| 06/27/2002 | US20020082256 Compounds useful as anti-inflammatory agents |
| 06/27/2002 | US20020082249 Prodrugs of aspartyle protease inhibitors |
| 06/27/2002 | US20020082248 Hydrochloric or hydrobromic salt reacted with sodium hydroxide in aqueous solution; formed sodium chloride and/or bromide are continuously removed via permselective membrane; solution is concentrated and sodium salt isolated by drying |
| 06/27/2002 | US20020082246 Prophylaxis and therapy of disorders in the course of which an increased activity of matrix-degrading enzymes is involved; these include degenerative joint disorders such as osteoarthroses and disorders of connective tissue |
| 06/27/2002 | US20020082242 Compositions and methods of double-targeting virus infections and cancer cells |
| 06/27/2002 | US20020082234 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 06/27/2002 | US20020082231 Utilizing ratC polypeptides to screen for antibacterial compounds |
| 06/27/2002 | US20020082226 Antisense antibacterial method and composition |
| 06/27/2002 | US20020082221 Nitric-oxide releasing lipid molecules selected from phosphoglycerides, lipids having a sphingosine base as a backbone, a monoglyceride, a diglyceride, a glycosylacylglycerol and a sterol containing S-N=O, N-N=O or |
| 06/27/2002 | US20020081723 Respiratory syncytial virus (RSV) fusion protein; treating or preventing RSV infection, as well as for diagnosis of RSV in analytes |
| 06/27/2002 | US20020081682 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of bacterial infections |
| 06/27/2002 | US20020081665 Composition for use as immunomodulatory and anticarcinogenic agents |
| 06/27/2002 | US20020081664 Expression and export of interferon-alpha proteins as Fc fusion proteins |
| 06/27/2002 | US20020081645 Coding or classification of prion sample; obtain sample, monitor physical properties of sample, compare to control |
| 06/27/2002 | US20020081627 Inhibition of adenovirus replication by product R, A peptide nucleic acid immunomodulator |
| 06/27/2002 | US20020081605 Method for detecting growth hormone variations in humans, the variations and their uses |
| 06/27/2002 | US20020081576 Antibodies directed against binding-associated epitopes |
| 06/27/2002 | US20020081573 Kit for detecting a respiratory syncytial virus in sample |
| 06/27/2002 | US20020081568 Hepatitis C virus NS5B truncated protein and methods thereof to identify antiviral compounds |
| 06/27/2002 | US20020081566 Hiv protein epitopes immunologically homologous to hla |
| 06/27/2002 | US20020081315 Methods and compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols |
| 06/27/2002 | US20020081304 Type f botulinum toxin and use thereof |
| 06/27/2002 | US20020081295 Virus-like particles for the induction of autoantibodies |
| 06/27/2002 | US20020081290 Protein kinase homologs |
| 06/27/2002 | US20020081279 In vitro manipulation of a plasmid-cloned chicken embryo lethal orphan (CELO) virus DNA, suitable for the production of vectors for gene therapy and as a vaccine against infectious diseases in human and animals, particularly birds |
| 06/27/2002 | DE10131641A1 St. John's wort extracts having reduced chlorophyll and proanthocyanidin contents, useful as topical medicaments, e.g. for treating stomatitis, acne, viral infections or psoriasis |
| 06/27/2002 | DE10061195A1 Verwendung von Abformmassen zur Herstellung von Behandlungsvorrichtungen Use of impression materials for the production of treatment devices |
| 06/27/2002 | CA2789252A1 Streptococcus pyogenes antigens and corresponding dna fragments |
| 06/27/2002 | CA2433308A1 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r4 |
| 06/27/2002 | CA2433027A1 Nucleic acid-associated proteins |
| 06/27/2002 | CA2432908A1 Diamines as modulators of chemokine receptor activity |
| 06/27/2002 | CA2432839A1 Method for the prevention, inhibition, or treatment of vaginitis and/or bacterial vaginosis using polystyrene sulfonate |
| 06/27/2002 | CA2432797A1 Local regional chemotherapy and radiotherapy using in situ hydrogel |
| 06/27/2002 | CA2432760A1 Isolated human dehydrogenases, nucleic acid molecules encoding them, and uses thereof |
| 06/27/2002 | CA2432429A1 Macrolide antibiotics |
| 06/27/2002 | CA2432417A1 Cyclin-dependent kinase (cdk) and glycolene synthase kinase-3 (gsk-3) inhibitors |
| 06/27/2002 | CA2432315A1 Methods for the production of multimeric proteins, and related compositions |
| 06/27/2002 | CA2432047A1 Immunogenic glycopeptides, screening, preparation and uses |
| 06/27/2002 | CA2431990A1 Method for modulating the binding activity of a novel icam-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 06/27/2002 | CA2431964A1 Conjugates of erythropoietin (pep) with polyethylene glycol (peg) |
| 06/27/2002 | CA2431820A1 Replication assay for detecting anti-viral substances |
| 06/27/2002 | CA2431740A1 A method to enhance the immune system and used for the prevention and treatment of infectious diseases |
| 06/27/2002 | CA2431721A1 Tetracyclic derivatives as spla2 inhibitors |
| 06/27/2002 | CA2431483A1 Antiviral agents |
| 06/27/2002 | CA2431446A1 High affinity antibodies |
| 06/27/2002 | CA2431074A1 Pharmaceutical formulation comprising thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (1) |
| 06/27/2002 | CA2431023A1 Substituted benzoindoles as spla2 inhibitors |